Meeting Archive:
A Practical Guide for 3D Cell Culture Systems and Optimizing Spheroid Imaging Assays - Part 2

This webinar has concluded. You can view the event recording here.
 
For more information on the products and technical resources from this presentation, please visit www.biotek.com.
 

Meeting Description:

Three-dimensional (3D) cell culture systems have become a well-established in vitro experimental approach to model human disease for a broad range of research applications. By enabling more physiological relevant cell-to-cell and cell-to-matrix interactions, 3D cell cultures present an attractive alternative to conventional 2D model systems. However, the increased complexity of 3D cultures, and growing number of available formats, requires thoughtful consideration to achieve consistent and accurate assay results.

In the second half of this webinar series on 3D cell culture we’ll build on the concepts covered in part one and present:
 
  • tips for effectively conducting quantitative analysis on spheroids
  • instruments and hardware features optimized for 3D cell culture samples
  • the experimental approach and analysis methods used in a variety of 3D cell culture applications, including cell proliferation and viability, migration and invasion, quantification of lipid droplet within a hepatic model, characterization of intestinal organoid morphology, and stem cell differentiation.
Details
Date: Wed, Oct 27, 2021
Time: 12:00 PM EDT
Duration: 1 hour
Host(s): BioTek
 Presenter Information
Brad Larson
Speaker Photo

Brad Larson is a Field Scientist and former Principal Scientist in the Applications group at BioTek Instruments. He has over 25 years of experience in the Biotech industry, and gained extensive experience with a variety of microplate reader, liquid handling, and microscopy instrumentation and applications.  


Joe Clayton, Ph.D.
Speaker Photo

Joe Clayton is the Global Scientific Program Manager at BioTek Instruments, a part of Agilent, with a Ph.D. in Molecular, Cell, and Biomedical Sciences.